Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 19/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31409444 | 0.92 | ADORA1 (0.57) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL31409448 | 0.92 | ADORA1 (0.57) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL31409447 | 0.89 | ADORA1 (0.45) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL31371026 | 0.84 | ALDH1A1 (0.46) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL31371055 | 0.77 | ALDH1A1 (0.56) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL31409453 | 0.74 | ADORA1 (0.62) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL4429778 | 0.74 | ADORA1 (0.62) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A | |
| SCHEMBL25363058 | 0.73 | ADORA1 (0.60) | ADORA1ALDH1A1SMN1; SMN2ADORA2AADORA3 | |
| SCHEMBL30511878 | 0.73 | ADORA1 (0.60) | ADORA1ALDH1A1SMN1; SMN2ADORA2AADORA3 | |
| SCHEMBL13929510 | 0.73 | ALDH1A1 (0.61) | ADORA1ALDH1A1PKMSMN1; SMN2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038783-A1 | ADENOSINE LIGANDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS OR CHRONIC HEART FAILURE | LUCY THERAPEUTICS, INC. (US) | 2025-02-20 | — | — | WO | disclosed |